SEOM guideline for the treatment of malignant glioma

被引:7
作者
Berrocal, Alfonso [1 ]
Gil, Miguel [2 ]
Gallego, Oscar [3 ]
Balana, Carmen [4 ]
Perez Segura, Pedro [5 ]
Garcia-Mata, Jesus [6 ]
Reynes, Gaspar [7 ]
机构
[1] Hosp Gen Univ, Med Oncol Serv, ES-46014 Valencia, Spain
[2] Inst Catalan Oncol Duran & Reynals, Med Oncol Serv, Barcelona, Spain
[3] Hosp Santa Creu & Sant Pau, Med Oncol Serv, Barcelona, Spain
[4] Hosp Badalona Germans Trias & Pujol, Med Oncol Serv, Barcelona, Spain
[5] Hosp Clin San Carlos, Med Oncol Serv, Madrid, Spain
[6] Hosp Santa Maria Nai, Med Oncol Serv, Orense, Spain
[7] Hosp La Fe, Med Oncol Serv, E-46009 Valencia, Spain
关键词
Glioblastoma; Anaplastic astrocytoma; Anaplastic oligodendroglioma; Treatment; DIAGNOSED GLIOBLASTOMA-MULTIFORME; VINCRISTINE PCV; PHASE-II; TEMOZOLOMIDE; CHEMOTHERAPY; RADIOTHERAPY; PROCARBAZINE; LOMUSTINE; SURVIVAL; TRIAL;
D O I
10.1007/s12094-012-0839-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
High-grade gliomas are an infrequent disease diagnosed usually in the fifth or sixth decade. Careful histopathological diagnosis is essential because tumour grade and type condition the treatment. Magnetic resonance with gadolinium is considered the standard radiologic exploration and should be followed by tissue sampling. Treatment of these patients should be decided in a multidisciplinary committee. Surgery, radiotherapy and chemotherapy are the basis of patients' treatment, with the best results obtained when the three of them can be used.
引用
收藏
页码:545 / 550
页数:6
相关论文
共 24 条
[1]
Afra D, 2002, LANCET, V359, P1011
[2]
[Anonymous], J CLIN ONCOL S
[3]
Phase II study of temozolomide and cisplatin as primary treatment prior to radiotherapy in newly diagnosed glioblastoma multiforme patients with measurable disease.: A study of the Spanish Medical Neuro-Oncology Group (GENOM) [J].
Balaña, C ;
López-Pousa, A ;
Berrocal, A ;
Yaya-Tur, R ;
Herrero, A ;
García, JL ;
Martín-Broto, J ;
Benavides, M ;
Cerdá-Nicolás, M ;
Ballester, R ;
Balart, J ;
Capellades, J .
JOURNAL OF NEURO-ONCOLOGY, 2004, 70 (03) :359-369
[4]
Extended-schedule dose-dense temozolomide in refractory gliomas [J].
Berrocal, A. ;
Perez Segura, P. ;
Gil, M. ;
Balana, C. ;
Garcia Lopez, J. ;
Yaya, R. ;
Rodriguez, J. ;
Reynes, G. ;
Gallego, O. ;
Iglesias, L. .
JOURNAL OF NEURO-ONCOLOGY, 2010, 96 (03) :417-422
[5]
Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma [J].
Brada, Michael ;
Stenning, Sally ;
Gabe, Rhian ;
Thompson, Lindsay C. ;
Levy, David ;
Rampling, Roy ;
Erridge, Sara ;
Saran, Frank ;
Gattamaneni, Rao ;
Hopkins, Kirsten ;
Beall, Sarah ;
Collins, V. Peter ;
Lee, Siow-Ming .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (30) :4601-4608
[6]
Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma [J].
Brandes, Alba A. ;
Nicolardi, Linda ;
Tosoni, Alicia ;
Gardiman, Marina ;
Iuzzolino, Paolo ;
Ghimenton, Claudio ;
Reni, Michele ;
Rotilio, Antonino ;
Sotti, Guido ;
Ermani, Mario .
NEURO-ONCOLOGY, 2006, 8 (03) :253-260
[7]
PLACEBO-CONTROLLED TRIAL OF SAFETY AND EFFICACY OF INTRAOPERATIVE CONTROLLED DELIVERY BY BIODEGRADABLE POLYMERS OF CHEMOTHERAPY FOR RECURRENT GLIOMAS [J].
BREM, H ;
PIANTADOSI, S ;
BURGER, PC ;
WALKER, M ;
SELKER, R ;
VICK, NA ;
BLACK, K ;
SISTI, M ;
BREM, S ;
MOHR, G ;
MULLER, P ;
MORAWETZ, R ;
SCHOLD, SC .
LANCET, 1995, 345 (8956) :1008-1012
[8]
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402 [J].
Cairncross, Gregory ;
Berkey, Brian ;
Shaw, Edward ;
Jenkins, Robert ;
Scheithauer, Bernd ;
Brachman, David ;
Buckner, Jan ;
Fink, Karen ;
Souhami, Luis ;
Laperierre, Normand ;
Mehta, Minesh ;
Curran, Walter .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) :2707-2714
[9]
Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations [J].
Chinot, OL ;
Barrie, M ;
Frauger, E ;
Dufour, H ;
Figarella-Branger, D ;
Palmari, J ;
Braguer, D ;
Hoang-Xuan, K ;
Moktari, K ;
Peragut, JCC ;
Martin, PMM ;
Grisoli, F .
CANCER, 2004, 100 (10) :2208-2214
[10]
DAUMASDUPORT C, 1988, CANCER-AM CANCER SOC, V62, P2152, DOI 10.1002/1097-0142(19881115)62:10<2152::AID-CNCR2820621015>3.0.CO